SBIR/STTR Research Award

Polymeric matrix loaded with tick repellent or toxic compositions for incorporation into fabrics or for granular dispersal

Award identifier db50b7c21e9ce679e2402741cadb6397257073044db66275a3b6fe6667b7104eAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$2,775,723

Program and phase

SBIR · Phase II

Award year

2022

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
BANFIELDBIO INC
Proposal award date
2022-09-23
Contract end date
2025-08-31
UEI
JNAJTN8L1SA4
Solicitation number
PA21-259
Topic code
NIAID

Research abstract

Project Summary/Abstract Within the US, ticks transmit 18 human pathogens, one of the most serious being Lyme disease, with an estimated 476,000 cases per year. Current tick management and human repellent and toxic products were designed either with protection against ticks as an “after-thought” or through the use of a pyrethroid insecticide to which ticks are increasingly developing resistance. There is also a current push by consumers to use natural and organic pest control products. As global temperatures rise, leading to a higher incidence of tick-borne diseases, there is a critical need for improved tick management products. This Phase II application will build on the development of novel polymeric microparticles as carriers of non-volatile acaricides by BanfieldBio for the DWFP award on “Murine autodissemination for long-term, area-wide control of ticks”. Based on encouraging preliminary evidence, we propose to adapt the polymeric microparticles to manufacture microporous polymeric granules and fibers that can be formulated to release volatile repellents and toxicants. Formulated granules would be used in landscape treatments to kill and repel ticks, and the fibers would be woven into outerwear fabrics to protect humans from acquiring and being bitten by ticks. Candidate active ingredients are nootkatone and 2-undecanone, which could be used alone or in combination with each other and/or permethrin. The project will target two species, blacklegged ticks and lone star ticks, both of which are important vectors of human disease, and will employ laboratory and field experimentation to explore and develop both types of formulation into novel prototype products. The proposed research and development would culminate in five potential outcomes: 1) a proprietary polymeric microporous granular composition formulated with one or more repellent and/or toxic compounds, 2) a demonstration that the formulated granular composition is effective against immature and adult ticks, and ready for scale-up, testing and development as a landscape-level tick preventive treatment, 3) fabric incorporating proprietary polymeric microporous filaments formulated with one or more repellent and/or toxic compounds, 4) demonstration that the fabric formulated with one or more repellent and/or toxic compounds is effective against immature and adult ticks, 5) fabric formulated with one or more repellent and/or toxic compounds manufactured into gaiters, and ready for technology transfer to commercial fabric production and incorporation into multiple types of outerwear clothing. As applicable, patent applications will be filed, the results published in peer-reviewed journals, and pathways to operational implementation and commercialization will be identified and exploited.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

7 SBIR/STTR records share this UEI (2012–2022). Reported award amounts total $6,805,595. Reported amounts are not federal obligations.

Phases: Phase II, Phase I

Agencies: Department of Health and Human Services, Department of Agriculture

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.